151 related articles for article (PubMed ID: 38627588)
21. miR‑29 promoter and enhancer methylation identified by pyrosequencing in Burkitt lymhoma cells: Interplay between MYC and miR‑29 regulation.
Mazzoccoli L; Robaina MC; Bacchi CE; Soares Lima SC; Klumb CE
Oncol Rep; 2019 Aug; 42(2):775-784. PubMed ID: 31173259
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma.
Slezak-Prochazka I; Kluiver J; de Jong D; Smigielska-Czepiel K; Kortman G; Winkle M; Rutgers B; Koerts J; Visser L; Diepstra A; Kroesen BJ; van den Berg A
Oncotarget; 2016 Jan; 7(3):2391-400. PubMed ID: 26497687
[TBL] [Abstract][Full Text] [Related]
23. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
24. The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth.
Niu F; Kazimierska M; Nolte IM; Terpstra MM; de Jong D; Koerts J; van der Sluis T; Rutgers B; O'Connell RM; Kok K; van den Berg A; Dzikiewicz-Krawczyk A; Kluiver J
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32512858
[TBL] [Abstract][Full Text] [Related]
25. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
[TBL] [Abstract][Full Text] [Related]
26. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
27. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis.
Robaina MC; Faccion RS; Mazzoccoli L; Rezende LM; Queiroga E; Bacchi CE; Thomas-Tikhonenko A; Klumb CE
Ann Hematol; 2016 May; 95(6):881-91. PubMed ID: 27044389
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway.
Mao S; Jin J; Li Z; Yang W
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33325535
[TBL] [Abstract][Full Text] [Related]
29. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA Pleiotrophin promotes carcinogenesis in glioma via regulation of microRNA-122/SRY-box transcription factor 6 axis.
Chen C; Deng L; Nie DK; Jia F; Fu LS; Wan ZQ; Lan Q
Eur J Cancer Prev; 2020 Mar; 29(2):165-173. PubMed ID: 31609809
[TBL] [Abstract][Full Text] [Related]
31. The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation.
Chen LY; Wang L; Ren YX; Pang Z; Liu Y; Sun XD; Tu J; Zhi Z; Qin Y; Sun LN; Li JM
Mol Cancer; 2020 Nov; 19(1):164. PubMed ID: 33225938
[TBL] [Abstract][Full Text] [Related]
32. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
[TBL] [Abstract][Full Text] [Related]
33. miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma.
Bartolomé-Izquierdo N; de Yébenes VG; Álvarez-Prado AF; Mur SM; Lopez Del Olmo JA; Roa S; Vazquez J; Ramiro AR
Blood; 2017 Apr; 129(17):2408-2419. PubMed ID: 28188132
[TBL] [Abstract][Full Text] [Related]
34. miR-150 Suppresses Tumor Growth in Melanoma Through Downregulation of MYB.
Sun X; Zhang C; Cao Y; Liu E
Oncol Res; 2019 Feb; 27(3):317-323. PubMed ID: 29690954
[TBL] [Abstract][Full Text] [Related]
35. Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Vettraino M; Manerba M; Govoni M; Di Stefano G
Anticancer Drugs; 2013 Sep; 24(8):862-70. PubMed ID: 23797802
[TBL] [Abstract][Full Text] [Related]
36. MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth.
Niu F; Dzikiewicz-Krawczyk A; Koerts J; de Jong D; Wijenberg L; Fernandez Hernandez M; Slezak-Prochazka I; Winkle M; Kooistra W; van der Sluis T; Rutgers B; Terpstra MM; Kok K; Kluiver J; van den Berg A
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261009
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Cellular MicroRNA by HIV-1 in Burkitt Lymphoma Cells-A Pathway to Promoting Oncogenesis.
Ramorola BR; Goolam-Hoosen T; Alves de Souza Rios L; Mowla S
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573283
[TBL] [Abstract][Full Text] [Related]
38. The inhibition of circular RNA circNOLC1 by propofol/STAT3 attenuates breast cancer stem cells function via miR-365a-3p/STAT3 signaling.
Liu YP; Heng JY; Zhao XY; Li EY
J Transl Med; 2021 Nov; 19(1):467. PubMed ID: 34789263
[TBL] [Abstract][Full Text] [Related]
39. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
40. MicroRNA-520a attenuates proliferation of Raji cells through inhibition of AKT1/NF-κB and PERK/eIF2α signaling pathway.
Wang X; Wang P; Zhu Y; Zhang Z; Zhang J; Wang H
Oncol Rep; 2016 Sep; 36(3):1702-8. PubMed ID: 27461820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]